Belviq, the brand name for Lorcaserin, has been withdrawn from the U.S. market after repeated fears about its links to cancer.
On February 13th 2020, the FDA asked the makers of Belviq to remove the drug from the market. Patients were advised to immediately stop taking the drug and speak with their physician.
In this short 3 minute video, attorney Brian Mahany examines why the drug has been removed from pharmacies and what it means for patients.
The post Video Blog – Belviq Cancer Lawsuits and Compensation appeared first on Mahany Law.